Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice

This publication has 15 references indexed in Scilit:

• Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary
  Neuroscience Letters, 1987
• Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in Parkinsonian and normal human brains
  Biochemical and Biophysical Research Communications, 1987
• 4-Phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets
  Neuroscience Letters, 1987
• Inhibition of the Tyrosine Hydroxylase System by MPTP, 1-Methyl-4-phenylpyridinium Ion (MPP+) and the Structurally Related Compounds in vitro and in vivo
  European Neurology, 1987
• Mitochondria and the neurotoxicity of MPTP
  Trends in Pharmacological Sciences, 1986
• The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slices
  Brain Research, 1986
• The Clinical Syndrome of Striatal Dopamine Deficiency: Parkinsonism Induced by MPTP
  New England Journal of Medicine, 1985
• Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse
  Neuroscience Letters, 1985
• MPTP and parkinson's disease
  Trends in Neurosciences, 1985
• AETIOLOGY OF PARKINSON'S DISEASE
  The Lancet, 1983